Tong Ren Tang Technologies Co. Ltd
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes of Chinese medicine products in Mainland China and Hong Kong. It operates through The Company and Tong Ren Tang Chinese Medicine segments. The company also offers Chinese medicinal raw materials, ointments, foot care products, healthcare products, biological products, western medicine, cosmetics, tea dri… Read more
Tong Ren Tang Technologies Co. Ltd - Asset Resilience Ratio
Tong Ren Tang Technologies Co. Ltd (TGRNF) has an Asset Resilience Ratio of 1.75% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how Tong Ren Tang Technologies Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Tong Ren Tang Technologies Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $251.78 Million | 1.75% |
| Total Liquid Assets | $251.78 Million | 1.75% |
Asset Resilience Insights
- Limited Liquidity: Tong Ren Tang Technologies Co. Ltd maintains only 1.75% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tong Ren Tang Technologies Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Tong Ren Tang Technologies Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
PINK:NVSEF |
Drug Manufacturers - General | 0.13% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 7.18% |
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 2.74% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
Annual Asset Resilience Ratio for Tong Ren Tang Technologies Co. Ltd (2009–2024)
The table below shows the annual Asset Resilience Ratio data for Tong Ren Tang Technologies Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.75% | $251.78 Million | $14.41 Billion | -9.29pp |
| 2023-12-31 | 11.04% | $1.49 Billion | $13.51 Billion | +7.35pp |
| 2022-12-31 | 3.69% | $460.40 Million | $12.48 Billion | -1.85pp |
| 2021-12-31 | 5.53% | $641.62 Million | $11.59 Billion | +0.62pp |
| 2020-12-31 | 4.91% | $537.14 Million | $10.94 Billion | -3.90pp |
| 2019-12-31 | 8.81% | $922.54 Million | $10.47 Billion | -9.07pp |
| 2018-12-31 | 17.88% | $1.75 Billion | $9.77 Billion | +6.07pp |
| 2017-12-31 | 11.81% | $1.05 Billion | $8.88 Billion | +1.36pp |
| 2016-12-31 | 10.46% | $855.80 Million | $8.18 Billion | -1.22pp |
| 2015-12-31 | 11.68% | $724.26 Million | $6.20 Billion | +4.88pp |
| 2014-12-31 | 6.80% | $376.20 Million | $5.53 Billion | -0.95pp |
| 2013-12-31 | 7.75% | $398.99 Million | $5.15 Billion | +7.47pp |
| 2012-12-31 | 0.28% | $8.76 Million | $3.17 Billion | -2.28pp |
| 2009-12-31 | 2.56% | $48.35 Million | $1.89 Billion | -- |